Introduction {#s1}
============

GIRK (G protein-activated Inwardly Rectifying K^+^-channel) channels play fundamental physiological roles, such as control of heart rate and neuronal excitability, and are also highly implicated in disease such as addiction, depression, bipolar disorder, and cardiac arrhythmias ([@B16]; [@B32]; [@B63]; [@B112]; [@B69]; [@B79]). Opening of the channel is achieved by a highly recognized signaling cascade involving agonist binding to a G-protein Coupled Receptor (GPCR), which in turn activates heterotrimeric G-proteins (of the Gα~i/o~-type), to promote 'release' of Gβγ subunits. Then, direct interaction of Gβγ subunits with GIRK leads to channel opening and the appearance of the agonist-evoked current, I~evoked~ \[([@B59]; [@B77]; [@B56]; [@B97]); reviewed in ([@B10]; [@B13])\].

Despite more than four decades of studies, the details behind this prototypical activation scheme remain highly debated. For instance, it remains unclear how the different signaling proteins are arranged at the membrane to bring about robust and efficient channel opening, fast activation kinetics and, importantly, signaling specificity (the strong preference for GIRK activation by Gβγ derived from G~i/o~ rather than G~s~ or G~q~). Two contrasting mechanisms have been proposed \[reviewed in ([@B30])\]. The first, denoted collision coupling ([@B106]; [@B107]; [@B93]; [@B94]; [@B95]), assumes unrestricted diffusion of GPCRs, G-proteins, and effectors in the plasma membrane. After GPCR activation, GIRK activation occurs through random collisions with proteins of this cascade ([@B113]; [@B31]; [@B108]). According to this model, a single receptor may activate several G-proteins (as in visual system; ([@B2])) and, therefore, an increase in the number of receptors is expected to accelerate activation kinetics of I~evoked~. Indeed, this was observed for several GPCR-GIRK cascades ([@B113]; [@B116]; [@B31]; [@B45]). The second mechanism posits long-lived "preformed" complexes of GPCRs, G-proteins, regulatory proteins (e.g., Regulators of G Protein Signaling; RGS) and GIRKs in various combinations ([@B39]; [@B54]; [@B25]; [@B43]; [@B22]; [@B87]; [@B23]; [@B73]; [@B103]). In support, several lines of evidence indicate that Gβγ and Gα~i/o~ can associate with GIRKs, as early as in the endoplasmic reticulum (([@B76]; [@B83]); reviewed in ([@B125])), recruit G-proteins to the plasma membrane ([@B80]; [@B44]), and possibly remain associated at the plasma membrane ([@B25]; [@B76]; [@B81]; [@B7]; [@B46]). Further, in neurons, cardiomyocytes and heterologous expression models, some GIRKs exhibit an agonist-independent (basal) current (I~basal~) that is Gβγ-dependent, suggesting some kind of pre-coupling of GIRK with the G protein before the receptor has been engaged (reviewed in ([@B13])). We have also shown that GIRK1/2, but not the GIRK2 homotetramers, recruit G-proteins to the plasma membrane, favoring Gβγ over Gα ([@B80]; [@B44]). The preferential association with Gβγ explains the high, Gβγ-dependent I~basal~ of GIRK1/2, contrasting the small and Gβγ-independent I~basal~ of GIRK2 homotetramers ([@B86]; [@B121]). Together, these findings support the existence of dynamic G protein-GIRK complexes; however, whether they require permanent association is debated ([@B121]). It is conceivable that different signaling cascades may proceed at different modes, namely collision or preformed modes, or a mixture of the two (e.g., only G protein and effector are pre-coupled).

The preformed complex model can seamlessly account for specificity (i.e., preferential activation of the channel by Gβγ released from a particular type of Gα-subunit) as well as for the high speed of GPCR-induced activation of GIRKs ([@B35]; [@B39]), limited mainly by the kinetics of G protein cycle ([@B113]; [@B60]; [@B30]). However, specificity can also be quantitatively described in purely kinetic terms, i.e. collision coupling ([@B108]). For instance, if a particular Gα-type, namely Gα~i/o~, is quicker to provide Gβγ to the channel than other Gα's, it would appear as though the channel solely responds to Gβγ derived from that specific Gα ([@B108]). Indeed, heterologous overexpression of proteins of the β-adrenergic-Gα~s~ cascade can lead to activation of GIRK *via* Gα~s~-derived Gβγ ([@B56]; [@B5]; [@B108]). These results show that the system can indeed proceed, at least in some instances, *via* a collision coupling mechanism. Lastly, at high levels of expression of the reactants (proteins participating in the cascade), especially the GPCR, the kinetics and magnitude of effector activation *via* a collision coupling cascade would be indistinguishable from those attained by a preformed complex ([@B53]). Therefore, the nature and concentrations of the reactants strongly affect the speed and specificity of the responses, thereby making it hard to distinguish between different modes of activation. It is therefore critical to study these mechanisms by systematic "titration" of the interactors.

In the current work, we set out to understand the mode of coupling in the classical M2R-Gα~i/o~-GIRK cascade, by combining electrophysiological, fluorescence, and biochemical measurements in *Xenopus* oocytes with kinetic modeling. Specifically, we studied this cascade by systematically varying and quantifying surface densities of proteins involved in it, and monitored outcomes on GIRK activation. Next, we combine a Thomsen-Neubig-like mathematical model of GPCR activation ([@B104]; [@B124]) with extant models of GIRK activation by Gβγ to quantitatively describe GIRK activation in detail. We find that a collision coupling model faithfully reproduces both the fast activation kinetics of agonist-induced GIRK responses, and their dependence on GPCR surface density.

Methods {#s2}
=======

Ethical Approval and Animals {#s2_1}
----------------------------

Experiments were approved by Tel Aviv University Institutional Animal Care and Use Committee (permits M-08-081 and M-13-002). All experiments were performed in accordance with relevant guidelines and regulations. *Xenopus laevis* female frogs were maintained and operated as described ([@B14]). Briefly, frogs were kept in dechlorinated water tanks at 20 ± 2°C on 10 h light/14 h dark cycle, anesthetized in a 0.17% solution of procaine methanesulphonate (MS222), and portions of ovary were removed through a small incision in the abdomen. The incision was sutured, and the animal was held in a separate tank until it had fully recovered from the anesthesia and then returned to post-operational animals' tank. The animals did not show any signs of post-operational distress and were allowed to recover for at least 3 months until the next surgery. Following the final collection of oocytes, after 4 surgeries at most, anesthetized frogs were killed by decapitation and double pithing.

DNA Constructs and mRNA Injection {#s2_2}
---------------------------------

cDNA constructs of GIRK subunits, Gβ~1~, Gγ~2~, M2R, YFP-GIRK1 were described in detail in previous publications (see ([@B102]) for a detailed list). Fluorescent proteins (CFP and YFP) contained the A207K mutation to prevent dimerization ([@B123]). DNAs of M2R-CFP and M2R-YFP were produced by inserting the PCR product of the human M2R ([@B55]), flanked by EcoRI on both sides, in pGEM-HJ vector containing CFP (cerulean) or YFP flanked by EcoRI and HindIII, yielding M2R-C/YFP~CT~. The M2R-Gα~i3-C351G~ tandem cDNA was created by ligating the M2R cDNA sequence in frame with the Gα~i3-C351G~ cDNA, connected *via* a 6 nucleotide sequence GAATTC (EcoRI restriction site). Thus, the full primary sequences of M2R and Gα~i3-C351G~ are connected by a 2-amino acid linker, Glu-Phe. The DNA of GluR1~L507Y~ ([@B99]) was generously provided by Y. Stern-Bach (Hebrew University). All DNAs were cloned into pGEM-HE, pGEM-HJ or pBS-MXT vectors, which are high expression oocyte vectors containing 5' and 3' untranslated sequences of *Xenopus* β-globin ([@B57]), as previously described ([@B80]; [@B7]). mRNA was transcribed *in vitro* as described in ([@B14]) and precipitated overnight at -20°C with 4 M LiCl. mRNAs were divided into 1 to 2 μl aliquots and stored at -80°C. 50 nl of mRNA were injected into the equatorial part of oocytes, two to three days before the experiments.

Electrophysiology {#s2_3}
-----------------

Whole-cell GIRK currents were measured using two-electrode voltage clamp (TEVC) with Geneclamp 500 (Molecular Devices, Sunnyvale, CA, USA), sampled at 1 kHz and filtered at 200 Hz, at room temperature (21-23°C), as previously described ([@B86]), using agarose cushion electrodes ([@B92]) filled with 3M KCl, with resistances of 0.1--0.6 MΩ. Data acquisition and analysis were done using pCLAMP software (Molecular Devices). For recording, oocytes were placed in a fast-perfusion chamber (see [**Figure S1A**](#SF1){ref-type="supplementary-material"} and below). Holding potential was set to -80 mV. Basal GIRK currents (I~basal~) were measured by switching from physiological solution (low K^+^, ND96: 96 mM NaCl, 2 mM KCl, 1 mM CaCl~2~, 1 mM MgCl~2~, 5 mM Hepes, pH 7.5) to a high K^+^ solution (high K^+^, in mM: 24 KCl, 2 NaCl, 1 CaCl~2~, 1 MgCl~2~, HEPES, pH 7.5). For recording evoked currents (I~evoked~), solution was then switched to high K^+^ solution containing 10 μM acetylcholine (ACh). Addition of 5 mM Ba^2+^ (blocker of GIRK) was typically applied at the end of each recording to isolate non-GIRK currents and to calculate net GIRK currents. Total current (I~total~) was assessed by summing basal and evoked currents (I~total~= I~basal~+ I~evoked~).

In the perfusion system employed in these experiments, each perfusion tube (inlet) is directly incorporated into the bath chamber (shaped like a thin elongated bar), rather than *via* a manifold, ending \~3 mm from the oocyte in large diameter openings (see [**Figure S1A**](#SF1){ref-type="supplementary-material"}). The suction has also been incorporated directly into the bath, 1 mm above the level of the oocyte, to reduce the bath solution volume and to allow fast exchange of the solution. In order to access the solution exchange time, we employed an AMPA receptor (AMPAR) mutant; GluR1~L507Y~, which lacks fast desensitization ([@B99]). The activation time constant (τ~act~) of AMPAR activation is below 1 ms ([@B27]) and can therefore be considered essentially instantaneous compared to the slower kinetics of GIRK activation. 1 ng RNA of GluR1~L507Y~ was injected into *Xenopus* oocytes. 50 nl of 20 mM solution of EGTA was injected 2 hours before experiment, to prevent the appearance of Ca^2+^-dependent Cl^-^ currents ([@B15]). AMPAR was activated by applying saturating glutamate concentration (1 mM) to the bathing solution. A representative recording of AMPAR current is shown in [**Figure S1B**](#SF1){ref-type="supplementary-material"}. The rising phase of the response to glutamate, fitted to a single exponential function, was 88.6 ± 14.5 ms (n=9), indicating that the average solution exchange rate time constant of our perfusion system was about 90 ms.

Whole Oocyte Radioactive Quinuclidinyl Benzilate (QNB\*) Labeling {#s2_4}
-----------------------------------------------------------------

Whole oocyte binding experiments were performed as described in ([@B4]). Briefly, three days following mRNAs injection, oocytes were dropped into 200 μl of 0.67 nM QNB\* ([@B29]). After 1 min of incubation, the oocyte was taken to a washing chamber that contained 4000 μl of ligand-free solution (washing stage) and rapidly (after 1--2 s) removed to the scintillation liquid by use of a custom device. The device is composed of plastic holder that enables insertion of a pipetor with a standard pipette tip (volumes up to 200 μl) trimmed 4 mm from the edge. This ensures extraction of the oocyte with minimal amount of liquid. Then, individual oocytes were placed in vials to which 4 ml of scintillation fluid was added and counted with Packard 2100TR TriCarb Liquid Scintillation Analyzer. Specific binding was determined by subtracting the binding from native, uninjected oocytes.

Fluorescence Imaging {#s2_5}
--------------------

Imaging of fluorescence in the plasma membrane (PM) of whole oocytes was performed as previously described ([@B6]; [@B7]). Briefly, whole oocytes were placed in a glass-bottom dish, and all images were obtained from the animal hemisphere close to oocyte's equator (see [@B6]; [**Figure 2**](#f2){ref-type="fig"}-micrographs showing homogenous fluorescence in the animal pole). Imaging experiments were performed on a confocal laser scanning microscope (LSM 510 Meta, Zeiss, Germany) with 20x or 5x objective lenses, digital zoom = 2, pinhole 3 Airy units, equipped with a HFT 405/514/633 beam splitter. CFP was excited by 405 nm and emission was collected in the wavelength interval of 449-500 nm, peak emission 481 nm; YFP was excited by 514 nm and emission collected in the interval of 524-609 nm, peak emission: 534 nm. Analysis was done using Zeiss LSM software. The net intensity of fluorescence in the PM was measured by averaging the signal obtained from three standard regions of interest along the membrane with background subtraction ([@B6]). In each experiment, uninjected oocytes were tested for intrinsic fluorescence with the use of either lasers: 405 and 514 nm excitation. In all confocal imaging procedures, care was taken to completely avoid saturation of the signal. In each experiment, all oocytes from the different groups were studied using constant LSM settings.

Statistical Analysis {#s2_6}
--------------------

Statistical analysis was performed using SigmaPlot software (Systat Software, San Jose, California, USA). Data are presented as mean ± S.E.M. Two group comparisons were done using two-tailed student's t-test. Multiple group comparison was done using one-way analysis of variance (ANOVA), with *post hoc* Tukey tests. Activation kinetics (τ~act~) were obtained by fitting evoked currents by a mono-exponential fit.

Modeling and Simulation {#s2_7}
-----------------------

Steady state calculations for estimation of initial conditions were done with Matlab for Windows (Mathworks Inc., Natick, Massachusetts). System of algebraic equations is shown in [**Supplemental Material 2**](#SM1){ref-type="supplementary-material"} and was solved numerically. Time-course simulation was done utilizing Berkeley Madonna 8.3.23.0 (R. Macey and G. Oster, University of California, Berkeley) for Windows. System of ordinary differential equations was generated based on schemes shown in [**Figures 4A, B**](#f4){ref-type="fig"} and [**Figure 5B**](#f5){ref-type="fig"}, and solved numerically by the 4^th^ order Runge-Kutta method.

Estimation of GIRK-Gβγ Interaction Parameters {#s2_8}
---------------------------------------------

Reported GIRK-Gβγ affinity values span several orders of magnitude depending on estimation method (nM -- mM range, ([@B16])). Considering this we utilized available crystal structure of GIRK2-Gβγ (Protein Data Bank number 4KFM, ([@B118])) and two structures of GIRK1- Gβγ complex generated by homology modeling and protein-protein docking procedure ([@B67]) for structure-based prediction of protein-protein interaction free energy and affinity. In particular, the above mentioned structures were submitted to PRODIGY server ([@B119]) that calculated both free energy of interaction and K~D~ values utilizing algorithm which is based on correlation between number of interfacial contacts at the interface of a protein--protein complex and its experimental binding affinity together with properties of the non-interacting surface as described by [@B47]. The k~on~ (association rate constant values) were predicted utilizing Transcomp software ([@B75]). This software utilizes transient-complex theory developed by [@B1] for predicting protein-protein association rate constants. Coordinates supplied by structural data supplied in PDB format are used to generate the transient complex and rate constant is calculated based on the electrostatic interaction energy in the transient complex.

Results {#s3}
=======

Collision Coupling Between M2R and G~i/o~ in GIRK Cascade in *Xenopus* Oocytes {#s3_1}
------------------------------------------------------------------------------

In previous publications, we presented evidence for catalytic collision coupling between M2R and Gα~z~ ([@B113]) and GABA~B~ receptors with endogenous or coexpressed Gα~i/o~ ([@B45]) in the GPCR-G protein-GIRK cascade reconstituted in *Xenopus* oocytes. To examine whether this is also the case for the M2R-G~i/o~-GIRK cascade, and for the following quantitative description and kinetic modeling of the cascade, we first characterized the mode of M2R-G~i/o~ coupling using our previously developed strategy ([@B113]). Specifically, we initially assessed how changes in GPCR (M2R) concentration impacts the kinetics of activation (τ~act~) of I~evoked~ of heterotetrameric GIRK1/2 channels. Here, we used a saturating concentration of acetylcholine (ACh; 10 µM) to activate different densities of ectopic M2R, whereas the signal transduction from GPCR to the channel relied on endogenous G~i/o~ proteins. We employed a fast perfusion system with a time constant of solution exchange below 100 ms (see *Methods* and [**Figure S1**](#SF1){ref-type="supplementary-material"}). Importantly, in neurons and cardiomyocytes the τ~act~ of I~evoked~ is in the range 200-700 ms ([@B74]; [@B98]). Thus, our measurements of τ~act~ in the oocyte introduces an overestimation of GIRK1/2 activation kinetics. However, this overestimation is relatively minor, especially at low densities of M2R (see below). Our results show that the increase in the amount of mRNA of M2R per oocyte (i.e., increase in surface density) speeds up the activation of GIRK1/2 ([**Figure 1A**](#f1){ref-type="fig"}, red plot- mono-exponential fit from which we extract τ~act~), with a corresponding decrease in the time constant of activation ([**Figure 1B**](#f1){ref-type="fig"}). These results are consistent with those obtained for M2R-G~z~-GIRK and GABA~B~R-G~i/o~-GIRK cascades in this heterologous model ([@B113]; [@B45]).

![Increasing expression levels of M2R accelerates the activation of GIRK1/2. **(A)** -- a representative GIRK1/2 activation experiment. Oocytes were injected with the following RNAs: GIRK1 and GIRK2 (2 ng/oocyte each) and 500 pg/oocyte M2R. I~evoked~ was elicited by 10 µM ACh. Inset- zoom-in on the activation phase of I~evoked~ (black plot) and a mono-exponential fit (red). **(B)** -- kinetics of GIRK1/2 activation. Oocytes expressed a constant amount of GIRK1/2 (2 ng RNA/oocyte), with increasing levels of M2R, in the range 10-1000 pg/oocyte, and τ~act~ was determined by monoexponential fitting as shown in A (N=2-7 experiments, n= 13-25 cells).](fphar-11-01216-g001){#f1}

Estimation of Membrane Protein Density {#s3_2}
--------------------------------------

For detailed kinetic analysis of GIRK1/2 activation, we sought to estimate the densities of proteins involved in our system, explicitly GIRK1/2, M2R and G-protein subunits- Gα and Gβγ, by a quantitative approach previously developed in our lab ([@B121]). Briefly, channel density is typically calculated based on the maximal GIRK1/2 current (i.e., I~βγ~) measured in oocytes that coexpress Gβγ at saturating concentration (usually 5 ng/oocyte of Gβ RNA and 1-2 ng Gγ RNA). Under these conditions, the channel's open probability (P~o~) is \~ 0.105. Channel density in M2R-expressing oocytes can also be calculated from the total current obtained upon activation with saturating 10 µM dose of ACh (I~total~). I~total~ is the sum of agonist-independent GIRK1/2 current, I~basal~, and the ACh-elicited I~evoked~. We found that, for GIRK1/2, there is a stable relationship between I~total~ and I~βγ~ over a wide range of channel densities such that, on average, I~βγ~ = 2I~total~ ([@B121]). If I~βγ~ or I~total~ are known, GIRK1/2 density could be estimated using a modification of the classical equation ([@B36]):
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where i~single~ is the single channel current and N is the number of functional channels in the PM. The channel's surface density is defined as N/S, where S is the surface area of the cell (210^7^ µm^2^, deduced from oocyte's capacitance of \~200 nF ([@B15])). Based on data and calculations from ([@B121]), under the conditions used here (24 mM K^+^ external solution), the surface density for GIRK1/2 or YFP-GIRK1/GIRK2 can be estimated using a simple translation factor:
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In most experiments reported here, oocytes were injected with 1-2 ng or GIRK1 and GIRK2 m-RNA each. This generally elicited strong channel activity that corresponds to a "high density" group with an average surface density of \~21 GIRK1/2 channels/µm^2^ ([@B121]). There is a possibility of formation of functional GIRK2 homotetramers under these experimental conditions. However, the basal current we measured ranged between 3 to 5 µA (see [**Figure 2A**](#f2){ref-type="fig"}). In oocytes, injection of 1 ng mRNA of GIRK2 gives rise to basal currents of 0.05 - 0.2 µA ([@B86]). Therefore, under our experimental conditions, it is most likely that the predominant channels recorded are indeed GIRK1/2 heterotetramers. Moreover, the preferred stoichiometry of the homologous GIRK1/4 channel is two subunits of GIRK1 and two subunits of GIRK4, rather than GIRK4 homotetramers ([@B96]).

![Estimating the surface density of M2R-YFP. All data are from one experiment. **(A)** - (left) Representative micrographs of oocytes (membrane at equator) expressing equal amounts of RNAs of YFP-GIRK1 and GIRK2, and 1 ng M2R (wt). Injected YFP-GIRK1 mRNA amounts are indicated. (right) Representative currents from oocytes from the same experiment (from the same groups as in left panels). Note the gradual increase in I~basal~ and I~total~, reaching a plateau at 2 ng/oocyte of channel's RNA. The current measurements in this experiment were done with a slower perfusion rate and were not included in the kinetic analysis. **(B)** -- Representative micrographs of oocytes, injected with the indicated amounts of M2R-YFP, imaged at the same day and under identical settings as those in A. **(C)** -- I~total~ of YFP-GIRK1/GIRK2 channels as a function of channel's RNA dose. **(D)** -- calibration of the surface density of YFP. YFP-GIRK1 fluorescence (in arbitrary units, AU) is plotted versus channel density induced by the two lowest doses of GIRK RNA (\<1 ng/oocyte), within the linear range of fluorescence-current relationship. Channel density was calculated from I~total~ as explained in the text. The correlation between fluorescence and number of YFP-GIRK1 molecules is shown with superimposed linear regression line, extended to origin of coordinates. The regression equation was y=4x, i.e. one channel/µm^2^ corresponds to fluorescence intensity of 4 AU. Note that, since each channel has two YFP molecules, the calibration factor in this experiment is: 1 YFP molecule/µm^2^ = 2 AU. **(E)** --estimating the surface density of M2R-YFP, for RNA concentrations of 1, 2 and 5 ng/oocyte. YFP fluorescence, in AU, is shown on the left Y-axis. M2R-YFP surface density (right axis) was calculated using the calibration factor derived from YFP-GIRK1/GIRK2 measurements. The relationship between M2R-YFP RNA dose and M2R-YFP surface density was fitted with linear regression, extended to the origin of coordinates, in the form y=62.5x.](fphar-11-01216-g002){#f2}

Next, we employed YFP-GIRK1/GIRK2 as a "molecular ruler" to translate surface densities of the channel, obtained from current, to fluorescence measurements. Here, YFP density was assumed to be twice that of the channel, since each GIRK1/2 heterotetramer is believed to contain two GIRK1 subunits, by analogy with GIRK1/4 ([@B96]; [@B12]). First, we determined the conditions for optimal channel expression for the calibration procedure. We injected increasing amounts of YFP-GIRK1, GIRK2 and Gβγ RNAs and observed a linear relationship between I~βγ~ and YFP-GIRK1 fluorescence over the range of channel RNA doses of 0.2-1 ng/oocyte, in line with the assumption that fluorescence corresponds to functional channels ([**Figure S2**](#SF2){ref-type="supplementary-material"}). Linearity was lost at high RNA doses, suggesting that at high expression levels, some channels are non-functional (possibly not at membrane). In the experiment shown in [**Figure 2**](#f2){ref-type="fig"}, we expressed a range of doses of YFP-GIRK1/2 with 1 ng M2R RNA and measured surface levels of channel fluorescence and total GIRK currents in response to ACh ([**Figures 2A, C, D**](#f2){ref-type="fig"}). We also expressed a range of doses of M2R-YFP and monitored YFP surface levels ([**Figures 2B, E**](#f2){ref-type="fig"}). A linear relationship between YFP-GIRK surface density and I~total~ of YFP-GIRK1/GIRK was observed at low doses of RNA (below 1 ng) and this range was used for the estimation of YFP-GIRK1 density for calibration purposes ([**Figure 2D**](#f2){ref-type="fig"}). In the same experiment and with identical imaging settings, we measured the PM expression of M2R-YFP at different RNA doses and, using the calibration factor from [**Figure 2D**](#f2){ref-type="fig"}, calculated the PM density of M2R-YFP. [**Figure 2E**](#f2){ref-type="fig"} shows that the relationship between the RNA dose and M2R-YFP density was linear in the range 1 -- 5 ng RNA, yielding receptor densities of \~20 to \~300 M2R molecules/µm^2^.

There are reports showing that the density of ion channels can be higher at the animal hemisphere or enriched around the injection site, which may effectively increase the density of PM proteins (M2R) in these areas ([@B82]; [@B61]; [@B64]). The assumption of homogeneity of M2R and GIRK distribution is therefore an approximation, which gives very good agreement with experiment. Note that, even if all the receptors and channels are located exclusively in the animal hemisphere, the surface density will only be changed two-fold.

Quantifying the Relationship Between M2R-YFP Surface Density and GIRK1/2 Activation Parameters {#s3_3}
----------------------------------------------------------------------------------------------

To compare the PM expression of different M2R constructs used in this study, we injected a range of RNA doses of wild-type (*wt*) M2R, M2R-YFP and M2R-CFP and measured the number of QNB binding sites in the PM of intact oocytes utilizing the methodology developed by Ben-Chaim et al. ([@B4]). All three M2R constructs rendered similar number of QNB binding sites ([**Figure 3A**](#f3){ref-type="fig"}), showing that they express at similar levels. We could therefore extend the M2R-YFP RNA -- density relationship shown in [**Figure 2E**](#f2){ref-type="fig"} towards M2R*wt* and M2R-CFP.

![Quantitative analysis of dose-dependency of τ~act~ and amplitude of I~evoked~ on plasma membrane density of M2R-CFP. **(A)**-Whole cell radioligand-labeling by quinuclidinyl benzilate (QNB\*) shows that identical doses of injected RNA produce similar surface expression of M2R, M2R-CFP and M2R-YFP, for three different amounts of receptor RNAs. B-F, quantitative analysis of incremental expression of M2R-CFP reveals collision-coupling activation of YFP-GIRK1/GIRK2 channels. Oocytes were injected with constant mRNA amounts of YFP-GIRK1 and GIRK2 (1 ng each) but with increasing doses of M2R-CFP RNA. **(B)** -- RNA dose-dependent increase in the surface levels of M2R-CFP. Representative micrographs of oocytes (left) expressing m2R-CFP and summary of expression (right). RNA amounts of M2R-CFP RNA, in ng/oocyte, are indicated in yellow. n=7-12 oocytes in each group. **(C)** -- expression of M2R-CFP does not affect the surface level of YFP-GIRK1/GIRK2 except for the decrease at the highest dose of M2R-CFP, 25 ng/oocyte (\*\*, p\<0.01). Left panel shows representative micrographs of YFP-GIRK1/GIRK2 -- expressing oocytes. Numbers within the images indicate the amounts of M2R-CFP RNA, in ng/oocyte. Right panel shows summary of expression data (n=7-12 oocytes in each group). **(D)** -- representative normalized I~evoked~, elicited by 10 µM ACh in oocytes injected with the indicated amounts of M2R-CFP RNA. For simplicity, only the initial (activation) phase of I~evoked~ is shown. **(E, F)** -- τ~act~ is reduced **(E)** and I~evoked~ amplitude **(F)** is increased with increased surface density of M2R-CFP. AU, arbitrary units. τ~act~ and I~evoked~ data are from cells exemplified in B -- D; n=5-12 in each group.](fphar-11-01216-g003){#f3}

We next studied the impact of M2R-CFP surface density on activation parameters of YFP-GIRK1/GIRK2. We expressed a range of M2R-CFP receptor densities (with a constant amount of channel's RNA), by injecting 1-15 ng RNA/oocyte, and monitored the PM level of M2R-CFP ([**Figure 3B**](#f3){ref-type="fig"}) and YFP-GIRK1 ([**Figure 3C**](#f3){ref-type="fig"}) along with currents amplitude and τ~act~ of I~evoked~ ([**Figures 3D--F**](#f3){ref-type="fig"}). The level of YFP-GIRK1/GIRK2 remained unchanged at all doses of M2R RNA except when the receptor was injected at excessively high doses, 25 ng. This yielded a decrease in the PM level of the channel ([**Figure 3C**](#f3){ref-type="fig"}), likely due to non-specific competition of RNAs for the same pool of ribosomes ([@B78]) or a trafficking interference. We have, therefore, adjusted the amplitude of I~evoked~ for the change (even if slight) in channel's PM level ([**Figure 3F**](#f3){ref-type="fig"}). Together, we find that increase in M2R density (validated by fluorescence) is associated with a sharp rise in both the speed and amplitude of channel activation ([**Figures 3D--F**](#f3){ref-type="fig"}). Notably, maximal amplitude of I~evoked~ is obtained at lower PM densities of the receptor than those required to obtain the fastest activation (lowest τ~act~; compare [**Figures 3E**](#f3){ref-type="fig"}, [**F**](#f3){ref-type="fig"}). These observations are in-line with the predictions of the catalytic collision coupling model. Unexpectedly, we note that, though M2R-CFP expresses at equivalent levels as M2R*wt* ([**Figure 3A**](#f3){ref-type="fig"}), it exhibits slower kinetics at all RNA doses (compare [**Figures 1D**](#f1){ref-type="fig"}, [**3D--F**](#f3){ref-type="fig"}). Therefore, M2R-CFP was solely used to assess surface density of the receptor, but not for quantitative description of the native cascade, where we use M2R*wt*.

Modeling: G Protein Cycle Model {#s3_4}
-------------------------------

For quantifying the M2R-G~i/o~-GIRK1/2 cascade, we elaborated the [@B104] model of G-protein cycle by combining it with the ternary complex model developed by [@B18]. Of note, a similar approach was used by Falkenburger et al. for the description of another muscarinic receptor and cascade, namely the M1R-G~q~-phosphoinositide signaling mechanism and regulation of the KCNQ channels ([@B24]; [@B34]). A schematic representation of the G-protein cycle model is shown in [**Figure 4A**](#f4){ref-type="fig"}. List of reactions with corresponding rate constants is shown in [**Table 1**](#T1){ref-type="table"}. To maintain microscopic reversibility, we incorporated into the G-protein cycle model a G-protein dissociation step (i.e. RGα~GTP~Gβγ dissociation, reaction 7) and also a GPCR-independent dissociation step (reaction 10) ([@B89]; [@B120]). It must be emphasized that the rate constants for the latter reaction have been incorporated in the model of [@B108]. Gα~GTP~Gβγ dissociation rate has been reported by [@B37] and association rate could be estimated based on the microscopic reversibility assumption ([**Table 1**](#T1){ref-type="table"}, reaction 7). Furthermore, GDP/GTP exchange is split into two reversible reactions. Rate constants of GDP and GTP binding have been determined experimentally ([@B33]; [@B124]). We also incorporated GαGβγ nucleotide free state in the process which leads from Gα~GDP~ bound state to GTP bound state as proposed by Ross ([@B84]).

![Simulating activation kinetics and its dependence on M2R surface density. **(A)** -- scheme of the G-protein cycle. **(B)** -- graded contribution model of GIRK1/2 activation. Rate constants of reactions shown in A and B are summarized in [**Table 1**](#T1){ref-type="table"}. **(C)** --comparison of the experimentally observed and predicted ACh-evoked currents, with GIRK-Gβγ interaction parameters from two structural models, 4KFM and BS. **(D)** - representative analysis of the time course of GIRK1/2 activation. The experimental result (dotted black line) is from an oocyte injected with 0.5 ng M2R RNA. Superimposed are simulated currents according to graded contribution model of GIRK1/2 activation. The experimental parameters in this cell were: I~basal~ = 15.5 µA, I~total~= 22.8 µA. Estimated channel density was 36 channels/µm^2^. Initial concentrations of Gα and Gβγ available to the channel are: for the case of 4KFM model 3.23 molecules Gα~i~/channel and 0.45 molecules Gβγ/channel; for the case of BS model, 3.24 molecules Gα~i~/channel and 0.46 molecules Gβγ/channel. Each plot represents the recorded or simulated current normalized to its maximum. **(E)** -- mean τ~act~ values from all experiments with wild-type M2R, superimposed on data obtained from fitting of simulated time-courses according to different models. Each experimental point shows mean value of τ~act~ ± SEM from one experiment (n=3-7 oocytes). Simulated time courses were generated for the case described by Yakubovich et al. as "high density group", i.e. I~basal~ =13.36 µA, I~total~ =17.2 µA, n=21 channels/µm^2^. Amounts of available Gα and Gβγ molecules per one channel, that are required to obtain the observed I~evoked~, were calculated using the graded contribution model: with the BS structure-based parameters, 3.65 Gβγ and 0.39 Gα molecules/channel; with the for 4kfm structure-based parameters, 3.62 Gβγ and 0.38 Gα molecules/channel.](fphar-11-01216-g004){#f4}

###### 

Rate constants of GPCR mediated GIRK activation.

  ----------------------------------------------------------------------------------------------------------------
  Reaction                       k~on~ M^-1^s^-1^   k~off~ s^-1^      Reference                      Calculation
  ------------------------------ ------------------ ----------------- ------------------------------ -------------
  1\. R + A ⟺ RA                 3.33∙10^2^\        7∙10^-3^\         ([@B91])                       
                                 (k~1f~)            (k~1b~)                                          

  2\. R+G~GDP~⟺RG~GDP~           5.51∙10^6^\        1.6∙10^-1^\                                      (\*)
                                 (k~2f~)            (k~2b~)                                          

  3\. RG~GDP~ + A ⟺ RAG~GDP~     4.5∙10^6^\         4.87∙10^-1^\      ([@B91])                       
                                 (k~3f~)            (k~3b~)                                          

  4\. RA+G~GDP~⟺ RAG~GDP~        3.68∙10^8^\        5\. = 5∙10^-2^\   ([@B40])                       (\*\*)
                                 (k~4f~)            (k~4b~)                                          

  5\. RAG~0~+GDP⟺ RAG~GDP~       10^6^\             5\                ([@B124])                      
                                 (k~5b~)            (k~5f~)                                          

  6\. RAG~0~+GTP⟺ RAG~GTP~       10^6^\             .1\               ([@B124])                      
                                 (k~6f~)            (k~6b~)                                          

  7\. RAGα~GTP~ +Gβγ⟺ RAG~GTP~   10^6^\             15\               ([@B37])                       (\*\*)
                                 (k~7b~)            (k~7f~)                                          

  8\. RA+Gα~GTP~⟺ RAGα~GTP~      10^7^\             2\                ([@B124])                      
                                 (k~8b~)            (k~8f~)                                          

  9\. Gα~GTP~→ Gα~GDP~                              .02\              ([@B124])                      
                                                    (k~9f~)                                          

  10\. Gα~GDP~ + Gβγ ⟺ G~GDP~    0.7∙10^6^\         0.0013\           ([@B89])                       
                                 (k~10f~)           (k~10b~)                                         

  C~n~+ Gβγ⟺CGβγ~n+1~            (4-n)∙0.23∙10^6^   (n+1)∙0.037       Best scoring model, ([@B67])   (\*)

  (4-n)∙1.01∙10^6^               (n+1)∙0.14         4KFM, ([@B118])                                  
  ----------------------------------------------------------------------------------------------------------------

Notations in brackets are used in ordinary differential equations shown in [**Supplemental Material 2**](#SM1){ref-type="supplementary-material"}.

(\*) k~on~ and k~off~ estimated by PRODIGY and TRANSCOMP.

(\*\*) k~on~ adjusted, see text.

In order to estimate kinetic parameters of reactions of the model that have not been determined experimentally, we used the open-source software tools PRODIGY for the estimation of K~D~ values ([@B119]) and TRANSCOMP for estimating association rate constants ([@B75]). Lastly, we scrutinized the crystal structure of M2R with heterotrimeric G-protein (PDB: 6OIK) ([@B65]) for deriving the kinetic parameters related to M2R-G protein coupling ([**Table 1**](#T1){ref-type="table"}).

Modeling: Channel Activation Model {#s3_5}
----------------------------------

We made use of our previously described GIRK1/2 gating model ([@B121]), denoted "graded contribution model" ([**Figure 4B**](#f4){ref-type="fig"}). This model is based on the assumption that a channel that is occupied by 1 to 4 Gβγ molecules can reach the open conformation, but the contribution of each Gβγ-occupied state is different; the higher Gβγ occupancy, the higher the contribution to open probability. This model is based on studies of Sadja et al. and Ivanova-Nikolova et al. ([@B42]; [@B88]) on a highly homologous channel; GIRK1/4. To estimate the parameters of interaction between GIRK1/2 and Gβγ for the graded contribution model, we proceeded in a similar approach as done for the unknown parameters of M2R-G-protein interaction, namely we analyzed two structural models of GIRK-Gβγ complex. The first is the crystal structure of GIRK2 in complex with Gβγ ([@B118]) (PDB: 4KFM) and the second is a docking model for the GIRK1-Gβγ complex ([@B67]) (termed "best scoring model", or BS). Both models were subjected to analysis by PRODIGY and TRANSCOMP software from which we obtained K~D~ and k~on~ values of GIRK-Gβγ interaction. For calculating initial values for all channel and G-proteins states (i.e. before agonist application), a system of algebraic equations was numerically solved assuming that the reaction between GIRK-G protein is in steady-state ([**Supplemental Material 1**](#SM1){ref-type="supplementary-material"}). Time-course of activation of GIRK1/2 was simulated as a solution of system of ordinary differential equations ([**Supplemental Material**](#SM1){ref-type="supplementary-material"}, **Eq. 19--34**).

Simulation of GIRK1/2 Activation Time-Course and Amplitude {#s3_6}
----------------------------------------------------------

In order to validate our model, we simulated the experimentally observed GIRK1/2 activation by a step application of 10 µM ACh. We chose a representative recording in which 0.5 ng/oocyte M2R mRNA was injected. This corresponds to a PM expression of about 31 receptors/µm^2^, according to our calibrations (see [**Figure 2E**](#f2){ref-type="fig"}). We used available values of Gα and Gβγ for the activation of GIRK from its I~basal~ and I~total~ as previously described ([@B121]) (see [**Supplemental Material 1**](#SM1){ref-type="supplementary-material"}). We then simulated the evoked current of GIRK1/2 and compared with experimental values ([**Figures 4C, D**](#f4){ref-type="fig"}). We find that our developed model satisfactorily reproduces the fast kinetics and the amplitude of I~evoked~, with kinetic parameters of GIRK-Gβγ interaction obtained from both structural models tested (4KFM and BS).

Subsequently, we ran time-course simulations over a wide range of M2R receptor densities, 0.1 -- 100 receptors/µm^2^. The initial parameters of I~basal~ and I~total~ for these simulations were adopted from the "high density group" of GIRK1/2 channel expression obtained by injection of 1-2 ng (21.7 channels/µm^2^, I~basal~ = 13.36 µA and I~total~ = 17.2 µA; ([@B121])). In each simulation, τ~act~ was extracted from mono-exponential fit of the activation phase of I~evoked~, and the calculated values of τ~act~ versus receptor density were superimposed on the experimentally measured τ~act~ obtained from a large number of experiments with M2R*wt* ([**Figure 4E**](#f4){ref-type="fig"}). We find that that our model satisfactorily predicts the acceleration of activation rate with the increase in GPCR density. It also faithfully reproduces the real kinetics of the receptor, namely it reproduces the fastest kinetics of activation obtained when using high receptor densities.

Modeling Kinetics of M2R-Gα~i3~ Fusion Protein {#s3_7}
----------------------------------------------

We were curious as to how would our model behave, and how would the simulated results look, should we be able to force some players to be in complex with each other. We have previously achieved forcing the precoupling of GPCR to Gα by fusing M2R to Gα~z~ (tandem) ([@B113]). Notably, we found that the kinetics of GIRK activation were independent of the concentration of the tandem protein (see *Introduction*). Here, we similarly made a tandem protein consisting of M2R and Gα~i3~. Our initial tests showed that this tandem was functional and, furthermore, engendered faster activation than that obtained by the M2R-Gα~z~ tandem ([**Figure 5A**](#f5){ref-type="fig"}). This was expected because of the much slower G protein cycle kinetics of Gα~z~ ([@B113]). We also introduced the C351G mutation into Gα~i3~ to impart pertussis toxin resistance ([@B117]). This allowed us to silence endogenous Gα~i/o~ by expressing the A protomer of pertussis toxin, to avoid incidental collision coupling of the tethered M2R to non-tethered endogenous Gα~i/o~βγ and the ensuing Gβγ activation of GIRK ([@B113]). We find that the activation kinetics of I~evoked~ were remarkably stable and independent on the doses of M2R-Gα~i3-G351G~ ([**Figure 5A**](#f5){ref-type="fig"}, red plot), whereas the amplitude of I~evoked~ persistently increased with higher RNA dose of M2R-Gα~i3-G351G~ ([**Figure 5A**](#f5){ref-type="fig"}, black plot). These results confirm that increase in RNA dose of the tandem is accompanied by an increase in its surface density and, more importantly, indicate that low doses of the tethered receptor-Gα pair cannot provide enough Gβγ to activate the large number of channels. We then proceeded to develop a scheme of GPCR-Gα~i3~ tandem-mediated activation of GIRK1/2 ([**Figure 5B**](#f5){ref-type="fig"}) and subsequently simulated time-course of GIRK1/2 activation by a range of GPCR-Ga~i3~ tandem densities. Three possible scenarios were simulated: 1) M2R-Gα concatemer was assumed to have the same affinity to Gβγ as Gα, and no change in Gβγ concentration was assumed with concatemer expression; 2) M2R-Gα concatemer was assumed to have same affinity to Gβγ as Gα, and 1:1 increase in Gβγ concentration was assumed with concatemer expression; 3) M2R-Gα concatemer was assumed to have 10 fold lower affinity to Gβγ than Gα and no change in Gβγ concentration was assumed with concatemer expression. Simulated evoked currents and τ~act~ values show that, whereas I~evoked~ values increase with the increase in GPCR-Gα~i3~ density, τ~act~ values remain constant ([**Figures 5C, D**](#f5){ref-type="fig"}). These simulations thereby fully recapitulate the outcomes on channel activation *via* a preformed complex between the GPCR and the G protein and provide a unique and contrasting picture than what we obtain when all components are free (i.e., non-fused). Thus, these observations further support the collision-coupling nature of M2R to G protein signaling in the M2R-GIRK cascade reconstituted in *Xenopus* oocytes.

![Physical tethering of M2R and Gαi3 converts a collision coupling mechanism to a preformed-complex: experiment and simulation. **(A)** -- Incremental expression of fused M2R-Gα~i3~C351G (PTX-insensitive) in the presence of coexpressed A-protomer of pertussis toxin (PTX; 0.2 ng RNA/oocyte) shows increase in I~evoked~ with growing amounts of injected RNA (black plot), but kinetics of activation remain unchanged (red plot). Right- Histogram of evoked currents (black) and τ~act~ (red) of GIRK1/2 coexpressed with M2R*-wt*. Result shown are from one experiment; number of cells (n) tested in each group are shown above experimental points or in the bar. No significant change in τ~act~ was found (one way ANOVA, P = 0.154). Spearman correlation coefficient calculated for analysis of evoked currents \~ 1, P = 0.0167. **(B)** -- scheme of G-protein utilized to simulate GIRK1/2 activation by M2R-Gα~i3~C351G. Blue arrows and numbering denote reactions that are shared with M2R wt activation pathway, as described in [**Figure 4**](#f4){ref-type="fig"}. Red arrows denote reactions present only in the current scheme. The numbering of reactions and the rate constants are the same as in [**Table 1**](#T1){ref-type="table"}. **(C)** -- simulated I~eoked~ values obtained assuming a range of expression level of fused M2R-Gα~i3~C351G. **(D)** -- summary of τ~act~ obtained from fitting time-course of activation of GIRK1/2 by range of M2R-Gα~i3~C351G densities with mono-exponential function. Three possible scenarios were simulated for analysis of M2R-Gα~i3C351G~ experiments. Black bars; M2R-Gα concatemer is assumed to have same affinity to Gβγ as Gα, and no change in Gβγ concentration is assumed with concatemer expression. Red bars; M2R-Gα concatemer is assumed to have same affinity to Gβγ as Gα, and 1:1 increase in Gβγ concentration is assumed with concatemer expression. Green bars; M2R-Gα concatemer is assumed to have 10-fold lower affinity to Gβγ than Gα and no change in Gβγ concentration is assumed with concatemer expression. For simulation it was assumed that GIRK1/2 is expressed at levels similar to "intermediate density group" described in [@B121] i.e. under pre-expression conditions there are \~ 9.7 channels/µm^2^ and 3.5 Gβγ molecules/channel. It is also assumed that under PTX expression conditions most endogenous Gα~i3~ is ADP-ribosylated and subsequently degraded.](fphar-11-01216-g005){#f5}

Comparison to Cooperative Gating Model {#s3_8}
--------------------------------------

We next tested another detailed model of the GPCR-GIRK cascade based on collision-coupling published by [@B108], termed here cooperative gating model. This model incorporates the Thomsen et al. model of the G-protein cycle ([@B105]; [@B104]), and the receptor independent G-protein heterotrimer dissociation ([@B89]; [@B90]). This model assumes that channel activation is cooperative, i.e., each Gβγ binds to the channel with stronger affinity than the previous one. It also assumes that GIRK can open only when all four Gβγ-binding sites have been occupied. In the model, we applied affinities and rate constants from ([@B108]), including K~D~ of binding of the first Gβγ to GIRK of 60 µM, with a cooperativity factor µ=0.3 for the binding of each next Gβγ, to generate a system of differential equations analogous to Eq. 19-34 for the simulation of GIRK1/2 activation. The densities of Gβγ and Gα were as for standard conditions, specifically \~21 channels/µm^2^ and 31 M2R receptors/µm^2^ (as for simulation of "high density group" ([@B121]); 0.5 ng/oocyte RNA of M2R corresponds to \~ 31 receptors/µm^2^; see [**Figure 2**](#f2){ref-type="fig"}).

Since GIRK1/2 has a substantial GPCR-independent but Gβγ-dependent I~basal~ \[see ([@B86]) for details\], a certain excess of free Gβγ over Gα in the vicinity of the channel must be assumed ([@B121]), whatever the mathematical approach used to describe channel's behavior. Using the cooperative gating model equations (Eq.14-18) and parameters of GIRK-Gβγ interaction, as described by ([@B108]), we calculate that \~7 free Gβγ molecules are needed to account for the I~basal~ measured at "high density". We next tested various pairs of Gβγ and Gα densities and selected those which most closely recapitulated experimental measures for I~basal~ and I~total~ ([**Figure S3**](#SF3){ref-type="supplementary-material"}). Furthermore, for analysis, we selected the minimal number of Gβγ (out of tested pairs), with the corresponding amount of Gα molecules per channel that best reproduced the experimental data ([**Figure S3**](#SF3){ref-type="supplementary-material"}, **see legend**).

Using the abovementioned initial conditions, we simulated the time-course of GIRK1/2 activation for a range of M2R densities similar to as shown in [**Figure 4E**](#f4){ref-type="fig"}. Similar to data shown in [**Figure 3**](#f3){ref-type="fig"} (for M2R-CFP), [**Figures 1B**](#f1){ref-type="fig"} and [**4E**](#f4){ref-type="fig"}, the amplitude of the simulated I~evoked~ increased with receptor density,whereas τ~act~ showed persistent decrease with the growing densities. However, the τ~act~ obtained was much faster than that observed in our experiments or predicted by our model, and varied less (i.e., of narrow range; [**Figure 6B**](#f6){ref-type="fig"}). In order to determine the nature of this discrepancy, we compared similar kinetic steps between our model and that of cooperative gating model. We noticed that the GTP hydrolysis rate used by Touhara et al. is 100 times faster that used in other reports ([@B124]). We also note that this fast rate of GTP hydrolysis is characteristic for conditions in which RGS is present, such as observed in cardiac myocytes ([@B21]). In our case, *Xenopus* oocytes lack RGS and thus slower GTP hydrolysis rates are expected ([@B48]). Indeed, substituting slower hydrolysis rate constant into cooperative gating model restored channel activation kinetics to as obtained in our experiments ([**Figures 6C, D**](#f6){ref-type="fig"}).

![Simulation of GIRK1/2 activation according to cooperative gating model. **(A)** -- Simulated values of I~evoked~ obtained for a range of M2R densities. **(B)** -- τ~act~ of mono-exponential fit of simulated I~evoked~ obtained for a range of M2R densities. For A and B, the rate constants were taken from Touhara et al. (1) and it was assumed that Gβγ =16 molecules/channel and Gα = 9 molecules/channel (red circles). **(C)** -- Simulated I~evoked~ obtained from simulation with k~hydrolysis~ = 0.02 s^-1^ and a range of M2R densities. **(D)** - τ~act~ of mono-exponential fit of time-course from simulation of I~evoked~ with k~hydrolysis~ = 0.02 s^-1^ and a range of M2R densities. For calculations done in **(C, D)**, k~hydrolysis~ was assumed to be 0.02 s^-1^ and Gβγ = 9 molecules/channel and Gα = 2 molecules/channel (blue circles).](fphar-11-01216-g006){#f6}

Discussion {#s4}
==========

Summary of Findings {#s4_1}
-------------------

The main goal of this work was to develop a detailed kinetic model for the GPCR-G-protein-effector cascade based on experimental data obtained in a prototypical expression system, the *Xenopus* oocyte. As many key features for this cascade are still missing, we deemed it quintessential to measure reactant densities in the plasma membrane along a detailed description of current features (amplitudes and kinetics). We used fluorescently labeled GIRK1/2 as a 'molecular ruler" ([@B121]) and conducted a controlled and quantitatively monitored expression of the component proteins of the signaling cascade, the GPCR (M2R) and the effector (GIRK1/2). G-protein concentrations were measured in a previous work using two independent methods, the fluorescence measurements with YFP-GIRK1/2 as caliper, and by quantitative Western blots ([@B121]). Using a titrated expression approach (as previously developed by us; ([@B113])), we demonstrate that incremental expression of both wild-type and CFP-tagged M2R, M2R-CFP, is accompanied by acceleration (decrease in τ~act~) of channel activation, i.e., I~evoked~. In contrast, activation kinetics of GIRK responses elicited by an M2R-Gα~i3~ tandem, which necessarily mimics the case of a "preformed GPCR-G protein complex", were fast and invariable over a wide range of expression levels of the fusion protein. We combined these observations and data to develop a comprehensive mathematical model for the M2R-G-protein-GIRK1/2 signaling cascade with free M2R based on free diffusion of all components, and a modification of this model for the case of M2R-Gα~i~ "preformed complex". Our model faithfully recapitulates and predicts all the quantitative aspects of GIRK1/2 activation explored here: the acceleration of activation with increasing densities of M2R, the τ~act~ and the amplitude of I~evoked~, and the dependence of the amplitude, but not the kinetics, of GIRK currents elicited *via* the activation of the M2R-Gα~i3~ fusion protein. Our results strongly support the collision coupling mode of signaling between M2R and the G~i/o~ protein in the GPCR-G protein-GIRK cascade reconstituted in *Xenopus* oocytes. More broadly, our model, and a similar collision coupling type of model of Touhara et al. demonstrate that a purely diffusion-limited coupling mechanism can fully account for the fast kinetics of GIRK responses in excitable cells, without the need to assume a preformed complex. Importantly, our results emphasize the utility of our approach of controlled incremental GPCR expression to distinguish between different coupling modes in G protein-mediated signaling cascades.

Model of G Protein Cycle {#s4_2}
------------------------

The mathematical approach used to describe the GPCR-G-protein-effector cascade is well elaborated ([@B51]; [@B111]; [@B24]). Several models have been developed specifically for the analysis of GIRK activation. The first model of GIRK activation that also incorporated a G protein cycle of GIRK activation was published in 1988 ([@B8]). Subsequently, updated models have been developed by groups of Kurachi and Mackinnon ([@B70]; [@B71]; [@B108]). Though all these models implement Thomsen-Neubig style G-protein activation model ([@B104]; [@B124]), they differ in certain key details. In particular, the model proposed by [@B71] assumes two affinity states of GIRK to Gβγ and two affinity states of GPCR to agonist; however, the GPCR-agonist affinity states are not kinetically interconnected and unrelated to coupling to G-protein. These are incompatible with the well-established dependency of agonist affinity upon the G protein-GPCR association ([@B66]; [@B18]; [@B28]; [@B115]). The model proposed by [@B108] does not include an explicit bimolecular reaction of agonist binding to GPCR. Both models describe Gα~GTP~Gβγ heterotrimeric complex dissociation as an irreversible reaction, which precludes the implementation of the microscopic reversibility principle ([@B11]).

The G-protein cycle model presented here ([**Figure 4A**](#f4){ref-type="fig"}) is a logical development and, in a way, a synthesis of previously proposed models with certain improvements. In particular, receptor-agonist-G-protein interaction is formulated as a complete ternary complex model ([@B18]). Both Gα~GTP~-Gβγ and Gα~GDP~-Gβγ interactions are described as reversible reactions. To enable the implementation of microscopic reversibility in the cycle, we have excluded the obligatorily irreversible GTP hydrolysis ([**Figure 4A**](#f4){ref-type="fig"}, reaction 9) from the main cycle. Including only reversible reactions in the circular parts of G-protein activation model makes the model more thermodynamically plausible. Moreover, we do not assume that the proteins in the cascade are in unlimited supply, and the equations of the model completely take into account "depletion" of proteins by excess of their binding counterparts. The only exception is GTP and GDP that are assumed to be in unlimited supply ("free ligand approximation", e.g. as is done for agonist in standard descriptions of agonist-receptor interactions).

Combining G-protein cycle model with GIRK1/2 gating model successfully reproduced the experimental observations. In particular, simulation of M2R*wt* expression experiment demonstrated similar decremental τ~act~ dependence on receptor density ([**Figure 4**](#f4){ref-type="fig"}), a feature that was subsequently nearly abolished when modeling the M2R-Gα tandem activation process ([**Figure 5**](#f5){ref-type="fig"}). These findings strengthen the notion that, in *Xenopus leaves* oocytes, M2R and G-proteins are not in "preformed complex", rather interact reversibly.

Channel Activation Models {#s4_3}
-------------------------

The process that leads to GIRK opening following the binding of Gβγ is still unclear ([@B26]). Currently there are three detailed GIRK gating models developed chronologically by Kurachi group ([@B38]; [@B70]; [@B71]), our group ([@B120]; [@B121]) and MacKinnon's group ([@B109]; [@B114]; [@B108]). The model proposed by Kurachi's group is based on Monod-Wyman-Changeux allosteric model of GIRK activation and formulates two binding states of Gβγ for each channel subunit. To complete the model, the authors used sub-nanomolar affinity for the GIRK-Gβγ interaction. The model developed by MacKinnon's group includes a detailed binding reaction of Gβγ to GIRK2 and GIRK1/4 and is based on elegant experiments with purified GIRK2 and Gβγ incorporated into bilayer membranes. In their work, they suggest that Gβγ binding is cooperative and that only channels occupied by four Gβγ undergo the closed-open transition ([@B114]). The model presented in the current work is based on sequential binding of Gβγ molecules to GIRK1/2 with graded contribution of each Gβγ-occupied state to open probability. Notably, this is based on ample experiments using the homologous heterotetrameric GIRK1/4 ([@B41]; [@B42]; [@B88]). Considering the different affinity values, reported in the literature, for GIRK-Gβγ interaction (see below), we derived the K~D~ values of this interaction from analyzing the available crystal structure of GIRK2-Gβγ ([@B118]) and the docking model of GIRK1-Gβγ ([@B67]). Notably, both estimates rendered K~D~ values (100-200 nM) on par with those measured in biochemical experiments, 100-800 nM ([@B49]; [@B19]). Furthermore, our model of channel activation, combined with the G protein cycle model, reliably reproduced the amplitudes of GIRK1/2 activations when we used the surface densities of the channel, GPCR and G-protein directly measured under physiological conditions. We note that, with an appropriate adjustment for the oocyte expression system, the cooperative gating model of [@B108] also reproduced the experimental data reported here, in terms of GIRK1/2 currents, τ~act~ and the dependence of τ~act~ on M2R density ([**Figure 6**](#f6){ref-type="fig"}). Interestingly, simulations done with the original parameters of the G-protein cycle model of Touhara et al. initially yielded a relatively shallow dependence of τ~act~ on M2R density, despite the fact that it is a collision coupling-type model. Analysis of this discrepancy lead us to the finding that τ~act~ dependence on receptor density even in "collision-coupling model" can be masked by a rapid rate of GTP hydrolysis, as can be obtained when RGS proteins are present ([**Figure 6**](#f6){ref-type="fig"}).

A more consistent discrepancy of this model's estimate with our estimates is related to estimations of the number of Gβγ and Gα molecules required for channel activation. The endogenous levels of Gβγ in oocyte's plasma membrane is in the range of 20-40 molecules/µm^2^, and is further increased to \~80 molecules/µm^2^ ([@B121]) upon overexpression of GIRK1/2 that recruits additional Gβγ to the plasma membrane ([@B80]; [@B44]). Calculations with the Touhara et al. model showed that a minimum of 7 free Gβγ molecules need to be available at any time to account for the basal, GPCR-independent GIRK1/2 activity; at least 9 Gβγ and 2 Gα are needed to account for the observed I~total~ (I~basal~+I~evoked~) ([**Figure S3**](#SF3){ref-type="supplementary-material"}). For 21 GIRK1/2 channel/µm^2^ (as observed after injection of 1 ng RNA of each subunit; ([@B121])), \~75 Gβγ molecules per m^2^ are required to attain the total GIRK1/2 current according to our model, but \~180 Gβγ molecules per m^2^ are needed with the cooperative gating model. The differences in Gβγ estimates stem mainly from the distinct GIRK-Gβγ affinity estimates used: 60 µM for the first Gβγ bound, with progressively improved affinity for each following Gβγ in [@B108], vs. \~0.15 µM in our model ([**Table 1**](#T1){ref-type="table"}). An even greater discrepancy may be expected if one uses the K~D~ of \~300 µM for GIRK2-first Gβγ interaction, as estimated experimentally in lipid bilayer in the presence of Na^+^ (the natural condition in a living cell's cytosol) ([@B114]). [@B108] also note that, with such low affinity of interaction between GIRK and Gβγ, Gβγ surface densities needed for GIRK activation should be much higher than the physiological range. This leads them to propose that the GPCRs, G-proteins and GIRK channels interact in hot spots ([@B100]), where all components of the cascade are highly concentrated. Another possible explanation is that the actual affinity of GIRK-Gβγ interaction is higher than 200-300 µM K~D~ despite the measurements in lipid bilayer experiments ([@B114]) or in solution by nuclear magnetic resonance ([@B122]). Notably, these studies employed a mutant Gγ lacking lipid modification (geranylgeranylation, in the case of Gγ~2~) and it is established that lipid modification of Gγ is an important determinant of high-affinity interaction between Gβγ and its binding partners such as Gα and phosducin ([@B72]; [@B62]). Further study is needed to better determine the affinity of GIRK-Gβγ interactions in living cells.

Collision-Coupling Versus Preformed Complex {#s4_4}
-------------------------------------------

There is a longstanding debate regarding the existence, or lack, of diffusion-dependent steps in the GPCR-G-protein cycle. A large body of data suggests pre-formed (or dynamic) complexes between these proteins. For instance, measurement of diffusion coefficients of GPCRs demonstrate non-homogeneity, pointing to partial restriction of diffusion and possible organization of GPCRs in "islands" ([@B17]; [@B101]; [@B3]). Similar restriction in lateral mobility is noted for G protein ([@B50]). These observations are supported by studies showing that immobilized GPCRs can activate G-protein molecules with the same rate as mobile GPCRs ([@B58]). Going downstream in the cascade, the dissociation of Gα from Gβγ during the activation process also remains questioned. Whereas the dogma states full dissociation and diffusion of the latter, it has been shown that some Gα and Gβγ may not undergo dissociation, rather undergo spatial rearrangement after activation ([@B9]; [@B52]). Onwards, complexes between G-protein and effectors, such as GIRK, have been noted ([@B83]; [@B125]) as well as even larger supramolecular complexes consisting of GPCRs, G-proteins and modulating molecules, such as RGS, have been demonstrated ([@B54]; [@B20]).Despite this body of work, pure collision coupling has also been demonstrated in many other cases (see introduction). Notably, the distinction between the two different modes is not trivial. In the current study, we elaborate our protocol using "titration" of proteins densities at the membrane, specifically those of the GPCR ([@B113]) and show that it allows to quantitatively distinguish between the modes of GPCR-G protein coupling.

We compared the kinetic properties of two different settings of M2R-G-protein interaction. The first consists of M2R-Gα fusion protein; a one-to-one relationship between the GPCR and Gα is enforced, giving rise to a *bona fide* "preformed complex". Notably, in the scenario, we also assume that the complex necessarily includes Gα~GDP~-Gβγ (in view of their very high nanomolar affinity), resulting in a full GPCR-G protein "preformed" complex. The second setting involves independent, untethered proteins. These two scenarios reveal that, whereas the kinetics of activation of GIRK by M2R*wt* are highly dependent on the receptor density, those of M2R-Gα fusion are not. This clear distinction strengthens the idea that, at least in *Xenopus* oocytes, M2R*wt* can indeed diffuse in the plasma membrane to activate several G-protein molecules (and GIRK subsequently). This conclusion is supported by studies, specifically conducted in *Xenopus* oocytes, demonstrating that, M2Rs and G-proteins are not permanently co-localized and diffuse unrestrictedly in the plasma membrane ([@B30]).

In summary, the current concept of GPCR-G-protein effector signaling may be schematically presented as three possible, and not mutually exclusive, paradigms. The first, the preformed complex model, is expected to follow first order kinetics, in which the rate of activation is concentration-independent. In the second, the catalytic collision coupling model, the rate of activation is anticipated to be highly concentration-dependent, at least for diffusion-limited cases. Of note, the dependence of activation kinetics on receptor density might also be influenced by G-protein inactivation rate. Indeed, we demonstrate this by employing the simulation of Touhara et al. with the slower GDP hydrolysis rate ([**Figure 6**](#f6){ref-type="fig"}). The third, is a mixture of the two. Importantly, the relationship of activation rate and concentration of the reactants is not trivial and is formulated, in most cases, as differential rate laws rather than as integrated rate law utilized for first order kinetic processes (useful for preformed complexes). It was previously shown that coupling reaction rate constant under diffusion limited conditions is equal to diffusion transport constant ([@B53]) and is therefore expected to be dependent on receptor density ([@B68]; [@B94]). Together, the dependence of GIRK's activation rate on the density of M2R most likely originates from this phenomenon as a result of collision coupling of GPCR and G-protein. The recently proposed "hot spot" interaction model of GPCR-G-protein activation ([@B101]; [@B100]) represents a particular case of collision coupling model (but not preformed complexes) and elegantly describes cases in which there is relatively low affinity between the reactants, because restrictions of molecules within a tight hot spot is expected to robustly increase their effective concentration. Further studies based on stochastic analysis of GPCR-G-protein-GIRK system and measurement of GIRK-Gβγ affinity will deepen our understanding of the above described phenomena.
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###### 

Kinetic measurements of time course of AMPA-R activation. **(A)** --configuration of the experimental chamber used for fast perfusion experiments. **(B)**-- a representative record (black dots) of current evoked by 1 mM glutamate. The red dots represent mono-exponential fit of the activation time course of the current (τ~act~=49.5 s).
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Click here for additional data file.

###### 

Linear relationship between Gβγ-activated YFP-GIRK1/GIRK2 current and total surface density is observed in the range 0-1 ng of YFP-GIRK1 RNA. **(A)** -- representative confocal images of oocytes expressing YFP-GIRK1/GIRK2. Channels were expressed by injecting the indicated doses of RNA of YFP-GIRK1 and GIRK2 (1:1) and activated by coexpression of 5 ng Gβ and 1 ng Gγ RNA. **(B)** -- correlation between total GIRK surface density and the Gβγ-dependent GIRK current, I~βγ~. I~βγ~ is the total agonist-independent current in Gβγ-expressing oocytes. It was measured in 24 mM K^+^ solution by subtracting the non-GIRK currents remaining after inhibition of \>95% GIRK activity by 5 mM Ba^2+^ ([@B85]). Total surface density is reflected in YFP fluorescence levels, functional channel density is proportional to I~βγ~. Correlation between I~βγ~ and fluorescence is linear for RNA doses of YFP-GIRK1/GIRK2 up to 1 ng/oocyte of each subunit. n = 6-12 for each point.
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Click here for additional data file.

###### 

Estimation of Gβγ and Gα densities for simulation with cooperative gating model. **(A)** -- I~basal~ currents rendered by different pairs of Gβγ and Gα densities selected for simulation. **(B)** -- I~total~ currents rendered by different pairs of Gβγ and Gα densities selected for simulation.Red bars indicate Gβγ and Gα densities used for calculations in [**Figures 6A, B**](#f6){ref-type="fig"}. Blue bars indicate Gβγ and Gα densities used for calculations in [**Figures 6C, D**](#f6){ref-type="fig"}. All calculations except the 9:2 Gβγ/Gα pair (blue bar) have been made for the condition of fast hydrolysis of GTP, k~hydrolysis~=2 s^-1^. The 16:9 Gβγ/Gα pair was the lowest dose of G protein subunits per channel that reproduced I~total~ under this condition. Lower doses of Gβγ/Gα produced lower I~total~. The 9:2 Gβγ/Gα pair was the lowest G protein subunits combination that reproduced I~total~ under the condition of low GTP hydrolysis rate (k~hydrolysis~=0.02 s^-1^).
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